Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chidamide in Relapsed or Refractory DLBCL and FL
NCT03410004Phase 2Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jan 2018
- Primary completion
- Sep 2019
01
Overview
A Phase 2 trial of tucidinostat in diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
tucidinostat
03
Conditions
diffuse large B-cell lymphoma (DLBCL)follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT03410004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03410004.